Navigation Links
Ex-Hong Kong Health Chief Favourite For WHO Top Job

Former Hong Kong health director Margaret Chan Tuesday emerged as favourite to become the new director-general of the World Health Organisation (WHO). //

The 60-year-old obstetrician, who led Hong Kong through the 2003 SARS crisis, topped a five-person shortlist of candidates released overnight ahead of a final round of voting in Geneva Wednesday.

Chan got 32 votes in the first round of voting Monday night, one more than Japan's Shigeru Omi while Mexico's Julio Frenk collected 30 votes.

The two other short-listed candidates to go forward to Wednesday's final vote from the original 11 candidates were Kuwait's Kazem Behbehani and Spain's Elena Salgado who each got 28 votes.

Chan joined the WHO where she has specialised in bird flu pandemic preparations after a controversial stint as Hong Kong health director during which her department was criticised for its slow initial response to the SARS outbreak.

China has enthusiastically thrown its weight behind Chan's candidacy.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Startling Expose – Physicians Often Have No Regular Source Of Health Car
2. Want a Healthy brew? Have some Tea!
3. Healthcare sector is now a multi billion-dollar industry in India
4. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
5. Health at heights
6. Health Officials Recommend Flu Vaccine
7. Slightly High BP Poses Health Risk
8. Unsatisfactory Grade On Womens Health Issues
9. Iodex goes to SmithKline Beecham consumer Healthcare
10. Healthy Medicine Or Harmful Intoxicant?
11. Healthy snacks improve nutrition of kids
Post Your Comments:
(Date:5/15/2008)...-869 to be Promising in Targeting Cancer Cells, ...TT PARK, Ill., May 15 /PRNewswire-FirstCall/ -- Ab... trial data of several investigative,compounds in ...rican,Society of Clinical Oncology (ASCO) Annual M...ntations include ABT-263, a Bcl-2 family protein,a...
(Date:5/15/2008)...inhua-PRNewswire-FirstCall/ -- China Yingxia,Inter...Yingxia" or "the,Company"), a leading provider in ...ent, manufacture and distribution of organic nutri...re products in the People,s Republic,of China ("PR...first,quarter ended March 31, 2008., First Quar...
(Date:5/15/2008)... goal of tailoring cancer treatment for each indiv...l Center today presented a study suggesting a simp...s treatment efficacy for patients with metastatic ...ometimes months to determine if a particular cance...ng to observe any significant radiographic changes...
(Date:5/15/2008)...n called IGF-1R in patients with gastrointestinal ...ient would be less responsive to the drug imatinib...K. Godwin, Ph.D., a researcher at the Fox Chase Ca...have shown that GIST cells, especially Gleevec-res...lopment for treatment-resistant breast cancer, a f...
Breaking Medicine News(10 mins):Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 2Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 3Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 4Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 5Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 6Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 2Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 3Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 4Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 5Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 6Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 7Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 8Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 9Health News:Study suggests blood test can help improve treatment outcomes for breast cancer patients 2Health News:Protein predicts Gleevec resistance in gastrointestinal tumors 2
...cipate seizures in children with epilepsy.The most...udy was // licking, often of the face, followed b...ctive" behavior without aggression. In previous st...that licking may abort or even prevent their seizu...
...feeling sick and with a number of other side effec...tment // and all they go through with it may not e...ng a new, more targeted approach to delivering che... aggressive way available to deliver chemotherapy ...
...icles and cause prostate cancer cells to grow. Low...shrink or grow more slowly. However, hormone thera... other treatments such as surgery or radiation are...common treatment for prostate cancer significantly...
...atment proves to be the best option to substantial...gery to remove part of the affected vein in additi...new treatment option for leg ulcers .Surgery did n...ms of venous ulcer healing, but recurrence rates w...
Other Medicine News:
(Date:5/15/2008)...s for an Antiplatelet Therapy that, Combined, with...n of Plavix/Iscover and Aspirin, According to ...ss., May 15 /- Decision Resources, on...ms for pharmaceutical and,healthcare issues, finds...provement in patient compared to Sanofi-Aventis/Br...
(Date:5/15/2008)...fter CEA Trial data reports in third quarter ...y 15 /- VIA Pharmaceuticals...ocused on the development of,compounds for the tre...that,it has completed patient enrollment in its ac...s one of three Phase 2 trials investigating VIA-22...
(Date:5/15/2008)... Annual Meeting of The American Society of ...-, IRVINE, Calif., May 15 /PRNewswire-FirstCall/ ... today announced the presentation of updated data,...amurtide (L-MTP-PE) in,patients with lung metastas... a rare and often fatal bone tumor that typically ...
(Date:5/14/2008)... /- Progen,Pharmaceuticals ...at the,Company has resumed patient enrolment in th...quired polyamine analogue, PG-11047 (formerly CGC-... has commenced development of PG-11047 - the lead ...am - following its acquisition of,Cellgate, Inc ea...
Breaking Medicine Technology:Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2CoAxia 28TM 29 Announces 2411 5M Equity Financing From Existing Investors 1669 1CoAxia 28TM 29 Announces 2411 5M Equity Financing From Existing Investors 1669 2Avandia May Slow Atherosclerosis After Bypass Surgery 15707 1Avandia May Slow Atherosclerosis After Bypass Surgery 15707 2Avandia May Slow Atherosclerosis After Bypass Surgery 15707 3NASA launches airborne study of arctic atmosphere air pollution 2708 1NASA launches airborne study of arctic atmosphere air pollution 2708 2NASA launches airborne study of arctic atmosphere air pollution 2708 3Daytime TV Addresses the Onslaught of MRSA Cases in U S 15703 1Daytime TV Addresses the Onslaught of MRSA Cases in U S 15703 2
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets.
The lower body blanket is utilized during surgical procedures covering the head, neck, arms and upper torso of your patient.
The Thermal pads were designed to simulate water immersion, the most effective method of transferring energy non-invasively.
This blanket is ideal for warming the large child or small adult during upper body surgery.
Medicine Products: